Towards the synthesis and delivery of a halogenated MCT1 substrate
<p>The monocarboxylate transporter 1 (MCT1) has received special attention as a potential therapeutic target in cancer thanks to its role in lactate shuttling. In breast cancer (BC), high MCT1 expression has been correlated with basal-like phenotype and a ‘triple-negative’ status, an aggressiv...
第一著者: | Skaripa-Koukelli, Eirini |
---|---|
その他の著者: | Vallis, K |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2019
|
主題: |
類似資料
-
Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review
著者:: Paul M. D. Gape, 等
出版事項: (2024-03-01) -
Imaging and therapy with radionuclide labeled magnetic nanoparticles
著者:: Perihan Ünak
出版事項: (2008-12-01) -
Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
著者:: Iturrioz-Rodríguez N, 等
出版事項: (2019-05-01) -
RNA nanostructures for targeted drug delivery and imaging
著者:: Laura Teodori, 等
出版事項: (2024-12-01) -
RGD Forever!—Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences
著者:: Johannes Notni
出版事項: (2022-12-01)